by Virtus | Dec 22, 2025 | Viral & Rhinovirus Models
Rhinovirus infection models are widely used in preclinical antiviral research to investigate respiratory viral pathogenesis, evaluate therapeutic efficacy, and support early-stage respiratory drug development. Rhinoviruses are a common cause of respiratory infections...
by Virtus | Dec 22, 2025 | Respiratory Preclinical Research
COPD preclinical models are widely used in respiratory drug development to evaluate disease-relevant mechanisms, assess translational potential, and generate early efficacy data before clinical studies. As a chronic airway disease with complex inflammatory,...
by Virtus | Dec 22, 2025 | Respiratory Preclinical Research
Asthma preclinical models play a critical role in respiratory drug development, enabling researchers to investigate disease mechanisms, evaluate therapeutic efficacy, and assess translational potential before clinical studies. These models are widely used in...
